Dose-Ranging Study to Determine the Optimum Dose for Imeglimin, a Novel Treatment for Type 2 Diabetes

被引：0
|
作者：
Fouqueray, Pascale
Bolze, Sebastien
Pirags, Valdis
Bailey, Clifford J.
Schernthaner, Guntram
Inzucchi, Silvio E.
Gerich, John E.
Roden, Michael
Lebovitz, Harold E.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1169-P
引用
收藏
页码：A301 / A301
页数：1
相关论文
共 50 条
  • [21] Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus
    Kiyosue, A.
    Hayashi, N.
    Komori, H.
    Leonsson-Zachrisson, M.
    Johnsson, E.
    DIABETES OBESITY & METABOLISM, 2013, 15 (10): : 923 - 930
  • [22] Treatment of sialorrhea with glycopyrrolate - A double-blind, dose-ranging study
    Mier, RJ
    Bachrach, SJ
    Lakin, RC
    Barker, T
    Childs, J
    Moran, M
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (12): : 1214 - 1218
  • [23] Efficacy of naratriptan tablets in the acute treatment of migraine:: A dose-ranging study
    Havanka, H
    Dahlöf, C
    Pop, PHM
    Diener, HC
    Winter, P
    Whitehouse, H
    Hassani, H
    CLINICAL THERAPEUTICS, 2000, 22 (08) : 970 - 980
  • [24] FRONTAL CEREBRAL THERMAL TRANSFER AS A TREATMENT FOR INSOMNIA: A DOSE-RANGING STUDY
    Nofzinger, E.
    Buysse, D. J.
    SLEEP, 2011, 34 : A183 - A183
  • [25] EPIDURAL LIPOSOMAL BUPIVACAINE IN THE RABBIT - A DOSE-RANGING STUDY
    MALINOVSKY, JM
    MEUNIER, JF
    BERNARD, JM
    LEGROS, F
    LEPAGE, JY
    ANESTHESIOLOGY, 1995, 83 (3A) : A816 - A816
  • [26] A DOSE-RANGING STUDY OF OLSALAZINE IN ULCERATIVE-COLITIS
    TRAVIS, SPL
    TYSK, C
    JARNEROT, G
    JEWELL, DP
    GUT, 1992, 33 (02) : S40 - S40
  • [27] Efficacy and safety of muraglitazar: a double-blind, 24-week, dose-ranging study in patients with type 2 diabetes
    Rubin, Cindy J.
    Viraswami-Appanna, Kalyanee
    Fiedorek, Fred T.
    DIABETES & VASCULAR DISEASE RESEARCH, 2009, 6 (03): : 205 - 215
  • [28] A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes
    Terra, S. G.
    Somayaji, V.
    Schwartz, S.
    Lewin, A. J.
    Teeter, J. G.
    Dai, H.
    Nguyen, T. T.
    Calle, R. A.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (07) : 401 - 407
  • [29] Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study
    Parikh, Asit
    Leach, Timothy
    Wyant, Tim
    Scholz, Catherine
    Sankoh, Serap
    Mould, Diane R.
    Ponich, Terry
    Fox, Irving
    Feagan, Brian G.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (08) : 1470 - 1479
  • [30] OnabotulinumtoxinA Dose-Ranging Study for Hyperdynamic Perioral Lines
    Cohen, Joel L.
    Dayan, Steven H.
    Cox, Sue Ellen
    Yalamanchili, Ramana
    Tardie, Greg
    DERMATOLOGIC SURGERY, 2012, 38 (09) : 1497 - 1505
12345